MYOS Corporation Announces Research Agreement with HMT America|
Friday, September 19, 2014
MYOS exploring potential role of myostatin inhibiting product on glucose and fat metabolism.
BGI, Imperial and Waters Sign Translational Medicine Agreement
Monday, September 15, 2014
The collaboration brings together three of the leading scientific groups in the field of translational medicine.
Waters Unveils Global Mass Spectrometry Headquarters in the UK’s North West
Thursday, September 11, 2014
The Right Honourable George Osborne MP joins Waters CEO Doug Berthiaume to mark the official opening of the Waters Mass Spectrometry Headquarters in Wilmslow.
Comparison of Caffeinated and Decaffeinated Coffee - Implications for Alzheimer's Disease
Monday, September 08, 2014
Researchers from the National University of Singapore successfully demonstrated the viability of GC-TOF-MS as an analytical platform for metabolomics analysis of coffee samples.
Cenix, Metanomics Partner to Develop Metabolomic Biomarkers
Friday, September 05, 2014
Companies sign a research framework agreement focused on comprehensive metabolite profiling services and the development of metabolomic biomarkers.
Metabolon, Baylor Partner to Screen for Inborn Errors of Metabolism
Thursday, September 04, 2014
The two-year, exclusive agreement will provide global Metabolomic-Assisted Pathway Screening (MAPS) services for individuals with suspected inborn errors of metabolism (IEMs).
Single Enzyme is Necessary for Development of Diabetes
Wednesday, August 20, 2014
12-LO enzyme promotes the obesity-induced oxidative stress in the pancreatic cells.
A New Player in Lipid Metabolism Discovered
Monday, August 18, 2014
Specially engineered mice gained no weight, and normal counterparts became obese on the same high-fat, obesity-inducing Western diet.
UT Southwestern Researchers Uncover New Brain Pathways
Saturday, July 26, 2014
New therapies for treating Type 2 diabetes and obesity.
|<<|| 1 2 3 4 5 6 7 || >>|
|Showing Results 1 - 10 of 1390|